“… hsa-miR-874 | Decreased expression was associated with poor overall survival of ESCC patients, targets STAT3 [ 101 ]. |
hsa-miR-5585 | Regulates cell cycle progression in human colorectal carcinoma cells, decreases expression of TGFβ-R1 , TGFβ-R2 , SMAD3 , and SMAD4 [ 102 ]. |
AAA—aortic abdominal aneurysm, AMI—acute myocardial infraction, CAD—coronary artery disease, EGFR—endothelial growth factor receptor, ESCC—esophagal squamous cells carcinoma, HCC—human colorectal cancer, HEY1—hairy/enhancer-of-split related with YRPW motif protein 1, HIF-1α—hypoxia induced factor 1α, HOXB1—homeobox B1, hUCMSCs—human umbilical cord mesenchymal stem cells, MALAT1—metastasis associated lung adenocarcinoma transcript 1, MAPK—mitogen activated protein kinase, mTOR—mammalian target of rapamycin, NF-κB—necrotic factor κB, NOTCH—translocation-associated protein, PI3K/AKT—phosphoinositide 3-kinases/protein kinase B, PTEN—phosphatase and tensin homolog deleted on chromosome ten, T2D—type 2 diabetes, TAA—thoracic aortic aneurysm, TGF-β—tumor growth factor β, TGFβ-R1—tumor growth factor β receptor 1, TGFβ-R2—tumor growth factor β receptor 2, SIRT7—sirtuin 7, SMAD3—decapentaplegic homolog 3, SMAD4—decapentaplegic homolog 4, STAT3—signal transducer and activator of transcription 3, SUFU—suppressor of fused homolog, Wnt—wingless-type MMTV integration site family of genes, VEGF—vascular endothelial growth factor, VEGFA—vascular endothelial growth factor A, VEGFR2—vascular endothelial growth factor receptor 2, VSMCs—vascular smooth muscle cells.…”